Obesity, inflammation, and cardiovascular risk (Q37702091)

22 August 2017

1 reference

title

Obesity, inflammation, and cardiovascular risk (English)

1 reference

22 August 2017

0 references

0 references

1 reference

P Mathieu

1 reference

22 August 2017

I Lemieux

series ordinal

1 reference

22 August 2017

J-P Després

series ordinal

1 reference

22 August 2017

language of work or name

English

0 references

publication date

3 March 2010

1 reference

Clinical Pharmacology & Therapeutics

22 August 2017

published in

1 reference

22 August 2017

1 reference

22 August 2017

1 reference

22 August 2017

page(s)

407-416

1 reference

Abdominal obesity and metabolic syndrome

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Visceral obesity and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Metabolic syndrome: a multiplex cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Inflammation in atherosclerosis: from pathophysiology to practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Visceral obesity: a "civilization syndrome".

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Longevity, lipotoxicity and leptin: the adipocyte defense against feasting and famine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Postprandial variations of plasma inflammatory markers in abdominally obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Dynamics of fat cell turnover in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

The metabolic syndrome and adipocytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Inflamed adipose tissue, insulin resistance and vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Metabolic syndrome: the danger signal in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Metabolic effects of interleukin-6 in human splanchnic and adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Cardiovascular biology of interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

The quest for the optimal assessment of global cardiovascular risk: are traditional risk factors and metabolic syndrome partners in crime?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Body composition, cardiorespiratory fitness, and low-grade inflammation in middle-aged men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Obesity, adiponectin and vascular inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

The contribution of adipose tissue and adipokines to inflammation in joint diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Resistin is an inflammatory marker of atherosclerosis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Before they were fat: adipocyte progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Antiinflammatory actions of HDL: a new insight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Effects of torcetrapib in patients at high risk for coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Impact of waist circumference on the relationship between blood pressure and insulin: the Quebec Health Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Low cardiorespiratory fitness levels and elevated blood pressure: what is the contribution of visceral adiposity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Weight loss and the renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Mechanisms of obesity and related pathology: linking immune responses to metabolic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Beta-cell failure as a complication of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

Cell-mediated immunity in genetically obese C57BL/6J ob/ob) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

inferred from DOI database lookup

7 January 2021

based on heuristic

Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.311

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2009.311

1 reference

Dimensions Publication ID

22 August 2017

1003683276

0 references

1 reference